Isonicotinic acid hydrazide (isoniazid; INH) inhibition of mycolic acid synthesis was studied by using cell extracts from both INH-sensitive and -resistant strains of Mycobacterium aurum. The cell extract of the INHsensitive strain was inhibited by INH, while the preparation from the INH-resistant strain was not. This showed that the INH resistance of mycolic acid synthesis was not due to a difference in drug uptake or the level of peroxidase activity (similar in both extracts). As INH did not induce accumulation of any labeled intermediates, it is postulated that the drug acts either on production of labeled chain elongation precursors of mycolic acids or an early step of this elongation. The level of inhibition was not changed by addition of NAD or nicotinamide; thus, INH does not act on mycolic acid synthesis as an NAD antimetabolite. Benzoic or acetic acid hydrazides and known or postulated metabolites of INH (i.e., the corresponding acid, aldehyde, or alcohol) were not inhibitors of cell-free mycolic acid synthesis; the complete structure of INH was required, as already known for inhibition of mycobacterial culture growth. Extracts prepared from INH-treated cells showed reduced mycolic acid synthesis, and the inhibition level was not modified by either extensive dialysis or pyridoxal phosphate. This latter molecule efficiently antagonized INH action by reacting rapidly with INH, as shown by differential spectroscopy. Moreover, pyridoxal phosphate did not release inhibition of INH-treated extracts. It is proposed that INH may covalently react with an essential component of the mycolic acid synthesis system.
Isonicotinic acid hydrazide (isoniazid; INH) very specifically inhibits growth in some mycobacteria and is one of the most efficient antituberculous agents. It has been used since 1952, but despite the great number of studies and reviews devoted to this drug its mode of action is not unequivocally known (for reviews, see references 5, 8, 14, 17, and 20) .
Three main hypotheses have been proposed to explain its activity. Two are based on the structural features and chemical reactivity of the molecule and state that INH may act as an antimetabolite of two major coenzymes, NAD (10; see also reference 5) and pyridoxal phosphate (14) . The third hypothesis postulates that INH inhibits a metabolism specific to mycobacteria, namely, mycolic acid synthesis (18, 21) . These compounds are very long-chain a-branched, ,-hydroxy fatty acids characteristic of mycobacterial cell walls. Production of isonicotinic acid and detection of iso-NAD (after 8 days of incubation) in treated mycobacteria supported the hypothesis of INH anti-NAD activity (5) . It was confirmed that INH inhibits various pyridoxal phosphate-requiring enzymes (8) .
The loss of acid fastness of INH-treated cells (7) suggested the hypothesis of inhibition of mycolic acid synthesis. It is based on early inhibition of this synthesis by INH in cells (17, 21) , on inhibition of C24-C26 monounsaturated fatty acid synthesis in cells (3) , and on inhibition of cell-free systems synthesizing very long-chain fatty acids (6) . However, there was no direct experimental evidence that these fatty acids were precursors of mycolic acids. Moreover, with intact cells it is impossible to discriminate between direct effects on mycolic acid synthesis and indirect effects due to general metabolism inhibition by INH acting as an antimetabolite.
We recently obtained the first cell-free system able to produce labeled mycolic acids from [14C]acetate as the * Corresponding author.
substrate (12, 13) . It is a particulate system associated with the cell wall. Use of a cell-free system eliminates unanswered questions about uptake, transport, and cytoplasmic metabolism of the tested drug. We determined whether inhibition of mycolic acid synthesis was due only to antimetabolite effects of INH against NAD or pyridoxal phosphate or whether this synthesis was one of the direct targets of the drug. We also determined whether INH acted in its intact form or after modification, for instance, transformed into isonicotinic acid by a peroxidase-catalase enzyme (4, 17) . Cell-free systems from strains sensitive or resistant to INH were used and compared.
MATERIALS AND METHODS
Cultures and cell-free system preparation. Two strains of Mycobacterium aurum were used: ATCC 23366 (INH resistant) and Institut Pasteur Collection strain A' (INH sensitive). Cultures were performed as previously described (11) .
Cell extracts were obtained by a procedure adapted from reference 12. About 6 g (wet weight) of cells from mid-log growth phase cultures were washed by centrifugation (0.01 M potassium phosphate, pH 7.0). The cells were suspended in 30 ml of cold buffer A (0.05 M potassium phosphate, 3 mM mercaptoethanol, pH 7.0) and broken twice in a cold French pressure cell (Aminco). Intact cells were removed by centrifugation (15 min, 3,000 x g), and the active cell-free preparation was recovered in the supernatant "fluffy layer." In some experiments, this fraction was sedimented twice (30 min, 40,000 x g) to eliminate soluble compounds. Under routine conditions, the fluffy layer was homogenized after addition of 4 to 6 ml of buffer A. This preparation is hereafter called the cell extract or cell-free system. The above-described operations were performed at 4°C.
When INH-treated bacteria (5 ,ug of INH per ml 1 h before harvesting) were used to prepare the cell-free system, the above-described conditions were used, except that the preparation was washed twice by centrifugation (buffer A, 30 min at 40,000 x g) or dialyzed (buffer A, overnight, 2 x 200 volumes) to eliminate free INH or derivatives. A control preparation of nontreated cells was submitted to the same treatment.
Cell-free mycolic acid synthesis. Incubation conditions were as follows, unless otherwise stated. A cell extract sample containing 2 to 3 mg of protein (as determined by the Lowry procedure) was used in a final volume of 1.5 ml of buffer B containing 70 ,umol of potassium phosphate (pH 7.0), 5 p.mol of MgCl2, 10 ,umol of HKCO3, and 10 ,umol of glucose (for M. aurum A' preparations only). A 30-min preincubation time (at 37°C) was used before the start of labeling by addition of [1-14C] acetate (70 nmol; specific activity, 1.9 GBq/mmol; CEA, Gif-sur-Yvette, France). Incubation times of up to 90 min were used (37°C on a rotary shaker at 160 rpm). The molecules and drugs tested were added at the beginning of the preincubation period. The reaction was stopped by addition of 1.5 ml of KOH (10%, wt/vol) in methanol-benzene (8:2, vol/vol). Fatty acids were obtained by overnight saponification in the above-described medium (at 70°C). Free fatty acids were extracted, and methyl esters were prepared by diazomethane.
The total radioactivity of each sample was determined by scintillation counting of samples. Esters were analyzed by thin-layer chromatography (Silica Gel G60 [Merck]; solvent, dichloromethane), and relative proportions of esters were determined by surface radioactivity counting on a linear automatic analyzer (LB 2832; Berthold). Spots were visualized by spraying with 20% sulfuric acid, followed by charring. The average activity of A' cell extracts was 5.2 x 103 ± 0.8 x 103 cpm/mg of protein per min of incubation (110 pmol of acetate incorporated per mg of protein per min).
Peroxidase activity. Peroxidase activity was determined with a final volume of 1 ml containing 2.6 ,umol of phenol, 0.8 ,umol of amino 2-antipyrine, 1 ,umol of MgCl2, 2 ,umol of HKCO3, 1.0 ,ul of 10 M H202, cell extract (around 1 mg of protein), and 0.1 M Tris-HCl buffer (pH 8.0). Incubations were performed at 37°C on a rotary shaker and absorbance was measured at 500 nm (the dye formed has an E500 of 12,000 M1 cm-'; two dye molecules are formed per H202 molecule consumed).
Chemicals. INH, isonicotinic acid, 4-pyridine carboxaldehyde, nicotinamide, NAD, isonicotinamide, pyridoxal, and pyridoxal phosphate were obtained from Sigma. Acetic acid hydrazide was from Merck, and benzoic and nicotinic acid hydrazides were from Aldrich. 4-Hydroxymethylpyridine was prepared by reducing 4-pyridinecarboxaldehyde with NaBH4.
RESULTS AND DISCUSSION Effects of certain factors on cell-free fatty acid synthesis.
The activities of cell extracts of the INH-sensitive (A') and -resistant (ATCC 23366) strains of M. aurum were compared (Table 1) . Both strains synthesize the same types of mycolic acids (unsaturated and oxo-and dicarboxymycolic acids), with differences in relative abundance. It appeared that 7 mM glucose greatly increased [14C]acetate incorporation into the three types of mycolic acids by strain A' cell extract but not in the strain 23366 preparation, while trehalose, an activator of cell extracts from Corynebacterium diphtheriae (19) , and ATP were without significant effect (Table 1) . Thus, 7 mM glucose was routinely added to A' preparations. Labeling of fatty acids from intact A' cells and from the cell-free system was determined by radioscanning ( Fig. 1A and Table 2 ). With the cell-free system, it appeared that 63% + 4% of the radioactivity was in mycolic acids (peaks 3, 4, and 5) and 11% ± 3% was in nonhydroxylated fatty acids (peak 6). Other labeled compounds were unidentified polar (peaks 1 and 2) and nonpolar molecules (peak 7), representing 20% ± 3% and 8% ± 2% of the total radioactivity, respectively. It is worth noting that the ratio of mycolic acids to nonhydroxylated fatty acids was significantly higher with the cell-free system than in intact cells (ratios of 6 and 2, respectively). The relative proportions of labeling in the three types of mycolic acids produced by the cell-free system (Table 2) were close to the actual proportions of mycolic acids in this strain (16) , with a higher oxomycolic and a lower dicarboxymycolic acid content. These differences could be due to the absence of regulation or the incubation conditions (as shown by the relative labeling of mycolic acids in intact cells incubated in the medium used for the cell-free system [ (Fig. 2) . As seen from the slopes of the curves in Fig. 2 shown that horseradish peroxidase presents a Youatt's enzyme activity close to that of M. tuberculosis peroxidase (4). Addition of horseradish peroxidase to INH-resistant cell extract (ATCC 23366) did not induce INH sensitivity (data not shown).
Thus, it can be said that the mycolic acid synthesis system of M. aurum is itself either sensitive or resistant to INH and also that the INH sensitivity of the cell-free system corresponds to the sensitivity of the strain. In addition, INH resistance of cell-free mycolic acid synthesis is not related to the level of peroxidase activity.
Can INH inhibition of mycolic acid synthesis be related to NAD depletion? As mentioned in the Introduction, it has been proposed that INH may block cell growth by leading to synthesis of metabolically inactive isomers of nicotinamide and NAD (10; see also reference 5). INH (0.1 mM) was added to the A' cell-free system in the presence of a 1 mM concentration of either nicotinamide, nicotinic acid hydrazide (known to antagonize INH activity), NAD+, or NADH. There was no significant release of INH inhibition in the presence of these compounds (data not shown). INH did not seem to act on this system as an antimetabolite of nicotinamide or NAD. INH metabolites are not active against mycolic acid synthesis. It is known that INH can be transformed by sensitive mycobacteria into isonicotinic acid and the corresponding alcohol (4-hydroxymethylpyridine), with an aldehyde as the postulated intermediate, and then possibly into isonicotinamide (10; see also reference 5). These four molecules were tested on both cell-free systems at twice the molar concentration used routinely for INH. None of the INH metabolites had a significant effect on mycolic acid labeling (Table 4) ; the hydrazide moeity was required for inhibition. Thus, other hydrazides were tested and it can be concluded from the results in Table 4 and from the beginning of this paragraph that acetic, benzoic, and nicotinic acid hydrazides had no effect on cell-free mycolic acid synthesis. These results are in agreement with the known structural requirements for INH, i.e., that both the isonicotinic structure and the hydrazide moiety are required to obtain significant inhibition of mycobacterial culture growth (9) .
Effect of INH in the presence of pyridoxal or pyridoxal phosphate. It was shown in early studies on M. tuberculosis growth inhibition by INH that compounds with a carbonyl group antagonize INH action, pyridoxal being the most active one (2, 15; see also references 8 and 14). These compounds react nonenzymatically with INH. Pyridoxal and pyridoxal phosphate were tested by adding them (independently at 1,090 ,iM) with INH (109 ,uM) at the beginning of the preincubation period of the cell-free system (see Materials and Methods). Pyridoxal had no effect (nearly 90% mycolic acid labeling inhibition), while pyridoxal phosphate nearly abolished the INH effect (10% inhibition). Such a difference between these two compounds was explained by their respective chemical reactivities. Differential spectroscopy (Fig. 3) showed that equimolar concentrations (150 ,uM) of INH and pyridoxal phosphate, mixed in the buffer used for cell-free mycolic acid labeling, reacted fast enough at room temperature to allow detection, within less than 0.5 h, of a newly formed molecular species with an absorption band at 290 nm (Fig. 3C ), while INH (Fig. 3A) and pyridoxal phosphate (Fig. 3B ) had quite different absorption maxima. The reaction was apparently complete after 2 days (Fig. 3D) pyridoxal phosphate reactivity. Thus, it can be postulated that INH is able to react quickly with pyridoxal phosphate on enzymes bearing this coenzyme. However, it is very unlikely that the effect of INH on the cell-free system was due to participation of pyridoxal phosphate in the synthesis, since the other hydrazides tested (at twice the concentration of INH) did not inhibit this synthesis (Table 4) , despite their high reactivities toward pyridoxal phosphate (data not shown).
Implication of a covalent bond between INH and the cellfree system. Since the hydrazide function is highly reactive, it may react chemically and form a covalent bond with a constituent of the cell-free system. To test this hypothesis, a mid-log-phase M. aurum A' culture was treated for 1 h with 5 ,ug of INH per ml, and then the cell-free system was prepared and either washed twice by centrifugation (40,000
x g) or dialyzed overnight to eliminate free INH or derivatives. Mycolic acid labeling was then determined. The cellfree system from INH-treated cells showed 52% inhibition (data not shown). This result supports the notion of covalent modification of the cell-free system.
Further evidence was brought by using the high reactivity of pyridoxal phosphate toward INH. Pyridoxal phosphate (1,090 ,uM) was added to the cell-free system prepared from INH-treated bacteria for 30 min of preincubation, and there was no release of labeling inhibition (data not shown).
Conclusion know that the cell-free system uses certain long-chain precursors present in the preparation (13) . In addition, with a powerful antagonist that reacts with INH (pyridoxal phosphate), it appeared that INH could act on mycolic acid synthesis by covalently reacting with some essential constituent of the system.
